Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Ozempic Rival Retatrutide Delivers 25% Weight Loss In Phase 3 Trial

    11 hours ago

    An experimental weekly weight-loss injection called retatrutide helped people with obesity lose an average of up to 25 per cent of their body weight after 80 weeks in a Phase 3 trial.
    Click here to Read More
    Previous Article
    IIT Kharagpur Alumnus, Skyroot CEO Pawan Chandana Among TIME's 100 Most Influential Rising Stars
    Next Article
    Stop Giving 100% At Work, Says Influencer: "Your Best Becomes Your Baseline"

    Related Breaking News Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment